79th WHA Individual Statements
We welcome the timely update of the Global Action Plan on AMR (GAP), which provides a unique opportunity to take stock of progress to date and redouble efforts in addressing gaps ahead of the planned 2029 UN AMR HLM. We are broadly supportive of the proposed strategic objectives and reiterate the urgent need to advance effective R&D incentives for antibiotics to address the growing burden of resistant infections. At the same time, we call on governments to work with industry in advancing sustainable access for antibiotics across different contexts, firmly grounded in a collaborative approach, including prioritizing the principle of VMAT for technology transfer.
IFPMA has maintained long-standing commitment to the issue of AMR. We stand ready to work with governments and other partners in advancing sustainable long-term solutions.